MEDNAX (MD) Tops Q3 EPS by 1c, Revenues Beat; Offers Q4 EPS Outlook

Go back to MEDNAX (MD) Tops Q3 EPS by 1c, Revenues Beat; Offers Q4 EPS Outlook

MEDNAX Reports Third Quarter Results

November 1, 2019 6:00 AM EDT

Completes Sale of MedData Business to Frazier Healthcare Partners

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)-- MEDNAX, Inc. (NYSE: MD), the national health solutions partner specializing in neonatology, anesthesiology, radiology, maternal-fetal medicine, and other pediatric services, today reported results from continuing operations for the three months ended September 30, 2019.

During the third quarter, the Company completed its annual goodwill impairment analysis and determined, based on various factors, that the fair value of certain of the Companys reporting units tested was below their carrying value. As a result, the Company... More